Global Veterinary Pain Management Drugs Market Size, Share and Trends Analysis Report, By Type (NSAIDs, Agonists, Anesthetics, Opioids, DMOADs, and Others), By Animal Type (Companion Animal and Livestock Animal), and By Application (Osteoarthritis, Musculoskeletal Disorders, Cancer, and Others) Forecast (2022-2028)

The veterinary pain management drugs market is anticipated to grow at a significant CAGR of 3.8% during the forecast period (2022-2028). Pain and inflammation linked with illnesses in animals are controlled with veterinary pain management drugs. These medications are used in the treatment of animal ailments and are an important component of veterinary therapy. The major players in the industry are working on a variety of targeted pain medications. Some of the factors propelling the growth of the global veterinary pain management drugs market includes the high prevalence of inflammatory and painful diseases amongst all animals. The frequency of osteoarthritis in dogs was estimated to be 20% globally, according to an article published by Veterinary Practice News in June 2020. Similarly, around 6 million dogs are diagnosed with cancer each year, according to an article released by the American Animal Health Association in April 2021. According to the Veterinary Cancer Society, one out of every four dogs will have cancer at some point, and around half of all dogs over the age of ten will develop cancer. Additionally, the rising government initiatives towards animal health concerns are driving the growth of the market. For instance, in October 2020, FECAVA launched a campaign titled “FECAVA Basic Practices in Anesthesia and Analgesia” which will include important lectures around Europe in the upcoming years and a series of six ready-to-use, printable posters/infographics regarding anaesthesia and pain management in animals.

The global veterinary pain management drugs market is segmented based on type, animal type, and application. Based on type, the market is sub-segmented into NSAIDs, agonists, anaesthetics, opioids, DMOAD, and others. Among these types, the opioids segment holds the major share in the market due to the added benefits of drugs in pain management. The opioids are mostly preferred by veterinary doctors for the treatment of inflammatory pain in animals. Based on animal type, the market is sub-segmented into companion animals and livestock animals. Based on application, the market is sub-segmented into osteoarthritis, musculoskeletal disorders, cancer, and others.

The market players are also contributing significantly to the market’s growth by adopting various strategies, including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in 2020, Cronus Pharma announced that it has got approval from the US Food & Drug Administration (FDA) for Carprofen Chewable Tablets (generic version of Rimadyl—Zoetis) for dogs. This nonsteroidal anti-inflammatory drug (NSAID) has been proven safe and effective in relieving pain and inflammation associated with osteoarthritis. Furthermore, it helps control postoperative pain associated with soft tissue and orthopaedic surgeries. Similarly, in January 2022, Elanco Animal Health announced that the company has received approval from the US FDA for Zorbium (buprenorphine transdermal solution) as it expands its pain management offerings while addressing an unmet need for veterinary practices.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Animal Type
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– Ceva Sante Animale, Zoetis Inc., Vetoquinol SA, Boehringer Ingelheim International GmbH, Bayer AG, Norbrook Laboratories Ltd., and Merck & Co Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Veterinary Pain Management Drugs Market Report by Segment

By Type

• NSAIDs
• Agonists
• Anaesthetics
• Opioids
• DMOADs
• Others

By Animal Type

• Companion Animals
• Livestock Animals

By Application

• Osteoarthritis
• Musculoskeletal Disorders
• Cancer
• Others

By Distribution Channel

• Veterinary Hospitals
• Clinics
• Others

Global Veterinary Pain Management Drugs Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa